SEC Form 5 · accession 0001140361-17-013942
Orgenesis Inc. · ORGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vered Caplan
Director
Period of report
Nov 30, 2016
Accepted (ET)
Mar 30, 2017 · 2:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001460602
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F1 | $0.001 | Apr 27, 2016 | A | 1,104,950 | A | Apr 27, 2016 | Apr 27, 2026 | Common Stock | 1,104,950 | 4,443,235 | D |
Explanation of responses
- F1On April 27, 2016, the Board granted Ms. Caplan fully vested options for 1,104,950 shares at the exercise price of $0.001 per share.